Authors: Brundin, P Karlsson, J Emgard, M Schierle, GSK Hansson, O Petersen, A Castilho, RF

Citation: P. Brundin et al., Improving the survival of grafted dopaminergic neurons: A review over current approaches, CELL TRANSP, 9(2), 2000, pp. 179-195

Authors: Mundt-Petersen, U Karlsson, J Schierle, GSK Brundin, P

Citation: U. Mundt-petersen et al., Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival, CELL TRANSP, 9(1), 2000, pp. 73-78

Authors: Brundin, P Schierle, GSK

Citation: P. Brundin et Gsk. Schierle, Neuroprotective strategies in neural grafting, NEUROMETH, 36, 2000, pp. 411-440

Authors: Hansson, O Castilho, RF Schierle, GSK Karlsson, J Nicotera, P Leist, M Brundin, P

Citation: O. Hansson et al., Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons, EXP NEUROL, 164(1), 2000, pp. 102-111

Authors: Schierle, GSK Hansson, O Ferrando-May, E Nicotera, P Brundin, P Leist, R

Citation: Gsk. Schierle et al., Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation, NEUROREPORT, 10(16), 1999, pp. 3347-3351

Authors: Schierle, GSK Hansson, O Brundin, P

Citation: Gsk. Schierle et al., Flunarizine improves the survival of grafted dopaminergic neurons, NEUROSCIENC, 94(1), 1999, pp. 17-20